Portable Rehabilitation Interface for Stroke

Overseen By Necolle Morgado-Vega

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Yale University

Disqualifiers: Vulnerable populations, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 6

Duration: 2-3 weeks

What You Need to Know Before You Apply

What is the purpose of this trial?

This randomized clinical trial compares the Portable Rehabilitation Interface (PoRI) device for rehabilitation of hand motor function in post-stroke patients with conventional hand therapy.

Who Is on the Research Team?

Necolle Morgado-Vega

Principal Investigator

Yale University

Are You a Good Fit for This Trial?

The PoRI Clinical Trial is for individuals who have had a stroke within the last 2 months and are experiencing hand paralysis or sensorimotor issues. They must have some muscle strength (0-3/5) in their fingers and be able to fit their hand into the rehabilitation device.

Inclusion Criteria

I have paralysis or trouble moving my fingers.

My muscle strength is rated between 0 to 3 out of 5.

My hand fits comfortably into the device.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive 20-minute sessions, 3 times per week for 2 to 3 weeks using either the PoRI device or standard care

2-3 weeks

6-9 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

2-3 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Portable Rehabilitation Interface (PoRI)

Trial Overview

This study tests the Portable Rehabilitation Interface (PoRI), a device designed to help improve hand motor function after a stroke, against traditional hand therapy methods. Participants will be randomly assigned to one of these two approaches.

How Is the Trial Designed?

Group I: Portable Rehabilitation Interface (PoRI) Experimental Treatment 1 Intervention

Participants will receive 20-minute sessions, 3 times per week for 2 to 3 weeks using the PoRI

Group II: Standard of care Active Control 1 Intervention

Participants will receive 20-minute sessions, 3 times per week for 2 to 3 weeks using standard of care

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials

1,963

Recruited

3,046,000+